FDA Compounding Advisory Panel Re-formed With Many Pending Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Fourteen committee members could give advice on Good Manufacturing Practices for registered outsourcing facilities as well as help determine list of drugs that cannot be compounded.